๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prospective randomized study of cyclophosphamide, epirubicin, and 5-fluorouracil versus cyclophosphamide, adriamycin, and 5-fluorouracil in advanced or recurrent breast cancer

โœ Scribed by Tetsuro Kobayashi; Hiroki Koyama; Takahiro Oka; Tadaki Yasumura; Norimichi Kan; Yuichi Takatsuka; Masakuni Noguchi; Ken Morimoto; Takaichiro Suzuki; Takayoshi Tobe; Takesada Mori

Publisher
Springer Japan
Year
1999
Tongue
English
Weight
475 KB
Volume
6
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cyclophosphamide versus cyclophosphamide
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial
โœ Hyman B. Muss; Virginia Howard; Frederick Richards Ii; Douglas R. White; Don V. ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 364 KB ๐Ÿ‘ 1 views

Thirty-two evaluable patients with metastatic carcinoma of the prostate were entered into a prospective randomized trial comparing cyclophosphamide (CYC) with a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF). Progressive disease after endocrine manipulation was noted in 97% (3

A randomized multicenter trial of cyclop
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer
โœ John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charl ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 388 KB

As of August 1984, 115 women with advanced breast cancer have been randomized to receive a combination of either cyclophosphamide, Novantrone (mitoxantrone) and 5-fluorouracil (CNF) or cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF). Seventy-one percent of all patients were post-